Abstract:Pancreatic stellate cells (PSCs) produce the stromal reaction in pancreatic cancer (PC), but their role in cancer progression has not been fully elucidated. Aims: To assess the influence of PSCs on PC growth using i) an orthotopic model of pancreatic cancer and ii) in vitro studies with cultured human PSCs and MiaPaCa2 (a human PC cell line). Methods: I) In vivo model: Athymic mice received an intrapancreatic injection of one of the following - saline (S), human PSCs (P), MiaPaCa2 cells (M), or human PSCs + MiaPaCa2 (1:1; P+M). After 7 weeks, mice were killed and tumor size and tumor spread assessed. Tumor histology was assessed with H&E, cytokeratin and α smooth muscle actin (αSMA) staining. II) In vitro studies: Effect of PSC secretions (from 3 separate human PSC preparations) on (a) PC cell proliferation - assessed by incorporation of 3H-thymidine into DNA of MiaPaCa2 cells incubated with PSC secretions for 24, 48 and 72h; (b) PC cell apoptosis - TUNEL staining used to assess basal and H2O2-stimulated MiaPaCa2 cell apoptosis, in the presence and absence of PSC secretions. Results: I) Orthotopic model: Mice injected with PSCs+MiaPaCa2 exhibited increased tumor size (Fig 1) and local and distant spread (Fig 2) compared to mice receiving MiaPaCa2 cells alone. No tumors were found in mice injected with PSCs alone. Morphometry of cytokeratin stained sections showed significantly higher epithelial cell numbers in the P+M group tumors compared to those in group M. αSMA staining revealed activated PSCs in fibrotic bands in P+M tumors with negligible staining in the other 3 groups. II) In vitro studies: (a) MiaPaCa2 proliferation was increased upon exposure to PSC secretions [24h - 217.4 ± 29.5*, 48h - 195.5±15.8*, 72h - 245.6±44.5* % of control; *p < 0.005]. (b) MiaPaCa2 apoptosis - Both basal and H2O2 stimulated apoptosis of MiaPaCa2 cells was significantly inhibited by PSC secretions. [Data as fold change: basal apoptosis 1; PSC secretions 0.45±0.05*, H2O2 16.39± 2.34**; H2O2+PSC secretions 3.59±0.81*; *p < 0.01].FIGURE 1: Primary tumour size. *p > 0.04: n = 5 mice/group.FIGURE 2: Local and distant spread. *p > 0.055: n = 5 mice/group.Conclusions: i) Pancreatic tumor growth and metastasis are significantly increased in mice receiving PSCs+MiaPaCa2 compared to those receiving MiaPaCa2 alone. The increase in tumor size is due to increased tumor cell number and not merely to fibrosis. ii) PSC secretions induce proliferation and inhibit apoptosis of PC cells. Implications: PSCs establish an environment that promotes tumor progression by stimulating proliferation and reducing apoptosis of pancreatic cancer cells.

Inhibition Of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation And Increases Survival Of Mice With Pancreatic Cancer

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

Inhibition of P21 Activated Kinase Enhances Tumour Immune Response and Sensitizes Pancreatic Cancer to Gemcitabine

PAK Inhibition by PF-3758309 Enhanced the Sensitivity of Multiple Chemotherapeutic Reagents in Patient-Derived Pancreatic Cancer Cell Lines.

P-038FRAX597, a PAK1 Inhibitor, Synergises with Gemcitabine in the Reduction of Pancreatic Cancer Growth

Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway

The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines

FRAX597, a PAK1 Inhibitor, Synergistically Reduces Pancreatic Cancer Growth when Combined with Gemcitabine

The role of p21-activated kinases in pancreatic cancer.

Depletion of P21-Activated Kinase 1 Up-Regulates the Immune System of APC∆14/+ Mice and Inhibits Intestinal Tumorigenesis

Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8

PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer

Reduced Expression of P21-Activated Protein Kinase 1 Correlates with Poor Histological Differentiation in Pancreatic Cancer

PANCREATIC STELLATE CELLS STIMULATE PANCREATIC CANCER GROWTH AND METASTASIS

Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications

Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion

Protein kinase D1 — A targetable mediator of pancreatic cancer development

P21-activated Kinase 1 Promotes Colorectal Cancer Survival by Up-Regulation of Hypoxia-Inducible Factor-1Α

A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine